Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology

Infection and Immunity

Volumn 83, Issue 4, 2015, Pages 1674-1683

  Levinson, Kara J ^a,b   Jesus, Magdia De ^a   Mantis, Nicholas J ^a,b  

^a WADSWORTH CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; LIPOPOLYSACCHARIDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2D6; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL FLAGELLUM; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ADHERENCE; CELL DIVISION; CELL MOTILITY; CHOLERA; CONTROLLED STUDY; CROSS LINKING; DIMERIZATION; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; INTESTINE EPITHELIUM; MICROBIAL ACTIVITY; MICROBIAL MORPHOLOGY; MORPHOTYPE; MOUSE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; VIBRIO CHOLERAE; ANIMAL; BAGG ALBINO MOUSE; FLAGELLUM; IMMUNOLOGY; INTESTINE MUCOSA; MICROBIOLOGY;

AGGLUTINATION; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; ANTIGENS, BACTERIAL; BACTERIAL ADHESION; CHOLERA; FEMALE; FLAGELLA; IMMUNOGLOBULIN A; IMMUNOGLOBULIN FAB FRAGMENTS; INTESTINAL MUCOSA; MICE; MICE, INBRED BALB C; POLYSACCHARIDES, BACTERIAL; VIBRIO CHOLERAE;

EID: 84925358248     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02856-14     Document Type: Article

References (45)

1. Harris JB, LaRocque RC, Qadri F, Ryan ET, Calderwood SB. 2012. Cholera. Lancet 379:2466-2476. http://dx.doi.org/10.1016/S0140-6736 (12)60436-X.
2. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE, Rudan I, Campbell H, Cibulskis R, Li M, Mathers C, Black RE, Child Health Epidemiology Reference Group of WHO and UNICEF. 2012. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:2151-2161. http://dx.doi.org/10.1016/S0140-6736(12)60560-1.
3. Pasetti MF, Levine MM. 2012. Insights from natural infection-derived immunity to cholera instruct vaccine efforts. Clin Vaccine Immunol 19: 1707-1711. http://dx.doi.org/10.1128/CVI.00543-12.
4. Guentzel MN, Berry LJ. 1975. Motility as a virulence factor for Vibrio cholerae. Infect Immun 11:890-897.
5. Lee SH, Butler SM, Camilli A. 2001. Selection for in vivo regulators of bacterial virulence. Proc Natl Acad Sci U S A 98:6889-6894. http://dx.doi.org/10.1073/pnas.111581598.
6. Millet YA, Alvarez D, Ringgaard S, von Andrian UH, Davis BM, Waldor MK. 2014. Insights into Vibrio cholerae intestinal colonization from monitoring fluorescently labeled bacteria. PLoS Pathog 10: e1004405. http://dx.doi.org/10.1371/journal.ppat.1004405.
7. Ritchie JM, Waldor MK. 2009. Vibrio cholerae interactions with the gastrointestinal tract: lessons from animal studies. Curr Top Microbiol Immunol 337:37-59. http://dx.doi.org/10.1007/978-3-642-01846-6_2.
8. Kirn TJ, Bose N, Taylor RK. 2003. Secretion of a soluble colonization factor by theTCPtype 4 pilus biogenesis pathway in Vibrio cholerae. Mol Microbiol 49:81-92. http://dx.doi.org/10.1046/j.1365-2958.2003.03546.x.
9. Bishop AL, Camilli A. 2011. Vibrio cholerae: lessons for mucosal vaccine design. Expert Rev Vaccines 10:79-94. http://dx.doi.org/10.1586/erv.10.150.
10. Centers for Disease Control and Prevention. 2012. Notes from the field: identification of Vibrio cholerae serogroup O1, serotype Inaba, biotype El Tor strain-Haiti, March 2012. MMWR Morb Mortal Wkly Rep 61:309.
11. Apter FM, Michetti P, Winner LS, III, Mack JA, Mekalanos JJ, Neutra MR. 1993. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun 61:5279-5285.
12. Winner L, III, Mack J, Weltzin R, Mekalanos JJ, Kraehenbuhl JP, Neutra MR. 1991. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect Immun 59:977-982.
13. Bishop AL, Schild S, Patimalla B, Klein B, Camilli A. 2010. Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect Immun 78:4402-4420. http://dx.doi.org/10.1128/IAI.00398-10.
14. Leitner DR, Feichter S, Schild-Prufert K, Rechberger GN, Reidl J, Schild S. 2013. Lipopolysaccharide modifications of a cholera vaccine candidate based on outer membrane vesicles reduce endotoxicity and reveal the major protective antigen. Infect Immun 81:2379-2393. http://dx.doi.org/10.1128/IAI.01382-12.
15. Majumdar AS, Dutta P, Dutta D, Ghose AC. 1981. Antibacterial and antitoxin responses in the serum and milk of cholera patients. Infect Immun 32:1-8.
16. Majumdar AS, Ghose AC. 1981. Evaluation of the biological properties of different classes of human antibodies in relation to cholera. Infect Immun 32:9-14.
17. Harris JB, Larocque RC, Chowdhury F, Khan AI, Logvinenko T, Faruque AS, Ryan ET, Qadri F, Calderwood SB. 2008. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis 2:e221. http://dx.doi.org/10.1371/journal.pntd.0000221.
18. Patel SM, Rahman MA, Mohasin M, Riyadh MA, Leung DT, Alam MM, Chowdhury F, Khan AI, Weil AA, Aktar A, Nazim M, LaRocque RC, Ryan ET, Calderwood SB, Qadri F, Harris JB. 2012. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin Vaccine Immunol 19:842-848. http://dx.doi.org/10.1128/CVI.00037-12.
19. Uddin T, Harris JB, Bhuiyan TR, Shirin T, Uddin MI, Khan AI, Chowdhury F, LaRocque RC, Alam NH, Ryan ET, Calderwood SB, Qadri F. 2011. Mucosal immunologic responses in cholera patients in Bangladesh. Clin Vaccine Immunol 18:506-512. http://dx.doi.org/10.1128/CVI.00481-10.
20. Mantis NJ, Forbes SJ. 2010. Secretory IgA: arresting microbial pathogens at epithelial borders. Immunol Invest 39:383-406. http://dx.doi.org/10.3109/08820131003622635.
21. Amarasinghe JJ, D'Hondt RE, Waters CM, Mantis NJ. 2013. Exposure of Salmonella enterica serovar Typhimurium to a protective monoclonal IgA triggers exopolysaccharide production via a diguanylate cyclasedependent pathway. Infect Immun 81:653-664. http://dx.doi.org/10.1128/IAI.00813-12.
22. Forbes SJ, Bumpus T, McCarthy EA, Corthesy B, Mantis NJ. 2011. Transient suppression of Shigella flexneri type 3 secretion by a protective O-antigen-specific monoclonal IgA. mBio 2(3):e00042-11. http://dx.doi.org/10.1128/mBio.00042-11.
23. Forbes SJ, Eschmann M, Mantis NJ. 2008. Inhibition of Salmonella enterica serovar Typhimurium motility and entry into epithelial cells by a protective antilipopolysaccharide monoclonal immunoglobulin A antibody. Infect Immun 76:4137-4144. http://dx.doi.org/10.1128/IAI.00416-08.
24. Forbes SJ, Martinelli D, Hsieh C, Ault JG, Marko M, Mannella CA, Mantis NJ. 2012. Association of a protective monoclonal IgA with the O antigen of Salmonella enterica serovar Typhimurium impacts type 3 secretion and outer membrane integrity. Infect Immun 80:2454-2463. http://dx.doi.org/10.1128/IAI.00018-12.
25. Wang J, Villeneuve S, Zhang J, Lei P, Miller CE, Lafaye P, Nato F, Szu SC, Karpas A, Bystricky S, Robbins JB, Kovac P, Fournier JM, Glaudemans CP. 1998. On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba. J Biol Chem 273:2777-2783. http://dx.doi.org/10.1074/jbc.273.5.2777.
26. Levinson K, Koestler B, Waters C, Mantis N. 2014. Protective anti-LPS monoclonal antibodies in Vibrio cholerae, abstr D-2094. Abstr 114th Gen Meet Am Soc Microbiol. American Society for Microbiology, Washington, DC. http://gm.asm.org.
27. Mekalanos JJ, Collier RJ, Romig WR. 1979. Enzymic activity of cholera toxin. II. Relationships to proteolytic processing, disulfide bond reduction, and subunit composition. J Biol Chem 254:5855-5861.
28. Miller WG, Lindow SE. 1997. An improved GFP cloning cassette designed for prokaryotic transcriptional fusions. Gene 191:149-153. http://dx.doi.org/10.1016/S0378-1119(97)00051-6.
29. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. 1992. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun 60:1786-1792.
30. Mantis NJ, Cheung MC, Neutra MR. 1999. Selective adhesion of IgA to murine intestinal M cells. Immunol Lett 69:42.
31. De Jesus M, Ahlawat S, Mantis NJ. 17 March 2013. Isolating and immunostaining lymphocytes and dendritic cells from murine Peyer's patches. J Vis Exp http://dx.doi.org/10.3791/50167.
32. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez JY, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676-682. http://dx.doi.org/10.1038/nmeth.2019.
33. Shigematsu M, Meno Y, Misumi H, Amako K. 1995. The measurement of swimming velocity of Vibrio cholerae and Pseudomonas aeruginosa using the video tracking methods. Microbiol Immunol 39:741-744. http://dx.doi.org/10.1111/j.1348-0421.1995.tb03260.x.
34. Liu Z, Miyashiro T, Tsou A, Hsiao A, Goulian M, Zhu J. 2008. Mucosal penetration primes Vibrio cholerae for host colonization by repressing quorum sensing. Proc Natl Acad Sci U S A 105:9769-9774. http://dx.doi.org/10.1073/pnas.0802241105.
35. Johnson RA, Uddin T, Aktar A, Mohasin M, Alam MM, Chowdhury F, Harris JB, LaRocque RC, Bufano MK, Yu Y, Wu-Freeman Y, Leung DT, Sarracino D, Krastins B, Charles RC, Xu P, Kovac P, Calderwood SB, Qadri F, Ryan ET. 2012. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin Vaccine Immunol 19:1712-1721. http://dx.doi.org/10.1128/CVI.00321-12.
36. Mantis NJ, Rol N, Corthesy B. 2011. Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol 4:603-611. http://dx.doi.org/10.1038/mi.2011.41.
37. Phalipon A, Cardona A, Kraehenbuhl JP, Edelman L, Sansonetti PJ, Corthesy B. 2002. Secretory component: a new role in secretory IgAmediated immune exclusion in vivo. Immunity 17:107-115. http://dx.doi.org/10.1016/S1074-7613(02)00341-2.
38. Williams RC, Gibbons RJ. 1972. Inhibition of bacterial adherence by secretory immunoglobulin A: a mechanism of antigen disposal. Science 172:697-699.
39. Gustafsson B, Holme T. 1985. Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies. Eur J Clin Microbiol 4:291-294. http://dx.doi.org/10.1007/BF02013655.
40. Asai Y, Kojima S, Kato H, Nishioka N, Kawagishi I, Homma M. 1997. Putative channel components for the fast-rotating sodium-driven flagellar motor of a marine bacterium. J Bacteriol 179:5104-5110.
41. Kulp A, Kuehn MJ. 2010. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu Rev Microbiol 64:163-184. http://dx.doi.org/10.1146/annurev.micro.091208.073413.
42. Kirn TJ, Lafferty MJ, Sandoe CM, Taylor RK. 2000. Delineation of pilin domains required for bacterial association into microcolonies and intestinal colonization by Vibrio cholerae. Mol Microbiol 35:896-910. http://dx.doi.org/10.1046/j.1365-2958.2000.01764.x.
43. Krebs SJ, Taylor RK. 2011. Protection and attachment of Vibrio cholerae mediated by the toxin-coregulated pilus in the infant mouse model. J Bacteriol 193:5260-5270. http://dx.doi.org/10.1128/JB.00378-11.
44. Boehm MK, Woof JM, Kerr MA, Perkins SJ. 1999. The Fab and Fc fragments of IgA1 exhibit a different arrangement from that in IgG: a study by X-ray and neutron solution scattering and homology modelling. J Mol Biol 286:1421-1447. http://dx.doi.org/10.1006/jmbi.1998.2556.
45. Villeneuve S, Souchon H, Riottot MM, Mazie JC, Lei P, Glaudemans CP, Kovac P, Fournier JM, Alzari PM. 2000. Crystal structure of an anti-carbohydrate antibody directed against Vibrio cholerae O1 in complex with antigen: molecular basis for serotype specificity. Proc Natl Acad Sci U S A 97:8433-8438. http://dx.doi.org/10.1073/pnas.060022997.